Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/08/2005WO2005116045A1 Compositions and processes using sirna, amphipathic compounds and polycations
12/08/2005WO2005116043A1 Novel amphiphilic compounds, preparation method thereof and applications of same
12/08/2005WO2005115481A2 Nuclease resistant double-stranded ribonucleic acid
12/08/2005WO2005115480A2 Modified protein kinase a-specific oligonucleotides and methods of their use
12/08/2005WO2005115479A2 Peptide conjugated, inosine-substituted antisense oligomer compound and method
12/08/2005WO2005115478A2 Methods and compositions for autism spectrum disorders
12/08/2005WO2005115476A1 Drug comprising as the active ingredient proliferative vector containing survivin promoter
12/08/2005WO2005115468A1 Novel drug discovery target and medicine acting on the same
12/08/2005WO2005115433A2 Methods for cyclizing synthetic polymers
12/08/2005WO2005115359A2 Methods and compositions for the treatment of uveitis
12/08/2005WO2005115358A2 Intranasal delivery of nucleic acid molecules
12/08/2005WO2005115303A1 Purification of insulin-like material by reverse phase chromatography
12/08/2005WO2005115136A2 Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases
12/08/2005WO2005115135A2 Mouse model of crohn’s disease and a method to develop specific therapeutics
12/08/2005WO2005115133A1 Method of gene introduction in in-vivo spermatogenic cell
12/08/2005WO2005115130A2 Transgenic ficus, method for producing same and use thereof
12/08/2005WO2005100586A3 Method for construction and use of kluyveromyces lactis promoter variants in k.lactis that substantially lack e. coli transcriptional capability
12/08/2005WO2005099771A3 Methods and compositions for treating neuropathic and neurodegenerative conditions
12/08/2005WO2005097828A3 Peptides of cav2.2 that inhibit pain
12/08/2005WO2005092374A3 Recombinant herpes simplex virus and uses therefor
12/08/2005WO2005089411A3 Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
12/08/2005WO2005087947A3 Bioengineered proteolytic enzymes with enhanced specificity for cytokine receptors
12/08/2005WO2005082098A3 Polony fluorescent in situ sequencing beads
12/08/2005WO2005078075A3 Hybrid proteins of active-site serine beta-lactamase
12/08/2005WO2005074470A3 Kits and methods for making large recombinant polynucleotides
12/08/2005WO2005067410A3 Synthetic nucleic acids from aquatic species
12/08/2005WO2005060721A3 Manipulation of rna interference through modulation of armitage activity
12/08/2005WO2005059172A3 Method and nucleic acids for the improved treatment of breast cell proliferative disorders
12/08/2005WO2005054432A3 Gene transfer for regulating smooth muscle tone
12/08/2005WO2005053725A3 Cancer treatment
12/08/2005WO2005047469A3 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
12/08/2005WO2005045035A3 RNA INTERFERENCE MEDIATED INHIBITION OF NOGO AND NOGO RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/08/2005WO2005021784A3 Estimation of activity or inhibition of processes involved in nucleic acid modification using chemiluminescence quenching
12/08/2005WO2005019410A3 Rnai agents for anti-sars coronavirus therapy
12/08/2005WO2005019408A3 Plants resistant to cytoplasm-feeding parasites
12/08/2005WO2005018534A3 Methods and compositions for rna interference
12/08/2005WO2005014779A9 Cyclodextrin affinity purification
12/08/2005WO2005011580A3 Compositions and methods for herpes simplex prophylaxis and treatment
12/08/2005WO2005005627A3 Applications of a new class of enzymes: sulfiredoxines.
12/08/2005WO2004111220A8 Proteases
12/08/2005WO2004058042A3 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
12/08/2005WO2004047531A3 Protein production in transgenic avians using lentiviral system
12/08/2005WO2003060148A3 Androgen regulated nucleic acid molecules and encoded proteins
12/08/2005WO2003045323A3 Anti-angiogenesis methods, compositions and uses therefor
12/08/2005WO2002079150A3 Glycorandomization and the production of novel erythronolide and coumarin analogs
12/08/2005WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
12/08/2005US20050273888 Transgenic expression cassettes for expressing nucleic acid sequences in sink tissues of plants that store carbohydrate
12/08/2005US20050273887 Stress resistant plants
12/08/2005US20050273886 Plastidic phosphoglucomutase genes
12/08/2005US20050273885 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
12/08/2005US20050273884 PUFA polyketide synthase systems and uses thereof
12/08/2005US20050273883 Pufa polyketide synthase systems and uses thereof
12/08/2005US20050273882 Expression of Cry3B insecticidal protein in plants
12/08/2005US20050273881 Defensin polynucleotides and methods of use
12/08/2005US20050273880 Polypeptides having oxaloacetate hydrolase activity and nucleic acids encoding same
12/08/2005US20050273879 Phytate polynucleotides and methods of use
12/08/2005US20050273878 Inbred corn line n61060
12/08/2005US20050273877 Inbred corn line m10138
12/08/2005US20050273876 Inbred corn line w16090
12/08/2005US20050273874 Method for producing heart-specific fluorescence of non-human eukaryotic animals
12/08/2005US20050273873 Genomic modification
12/08/2005US20050273872 Protein production in transgenic avians
12/08/2005US20050273870 Preparation and selection of donor cells for nuclear transplantation
12/08/2005US20050273869 Plasmids and phages for homologous recombination and methods of use
12/08/2005US20050273868 Methods and compositions for enhancing RISC activity in vitro and in vivo
12/08/2005US20050273867 Non-invasive real-time in vivo bioluminescence imaging of local Ca²+ dynamics in living organisms
12/08/2005US20050273270 Profile searching in nucleic acid sequences using the fast fourier transformation
12/08/2005US20050272924 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector
12/08/2005US20050272923 Mature microRNA prediction method using bidirectional hidden markov model and medium recording computer program to implement the same
12/08/2005US20050272864 Method and device for improving protein stability and solubility
12/08/2005US20050272767 Method for treating myolytic disease and method for screening antimyolytic agent
12/08/2005US20050272684 Breast cancer resistance protein (BCRP) and the DNA which encodes it
12/08/2005US20050272683 Antisense oligonucleotides against thymidylate synthase
12/08/2005US20050272682 SiRNA targeting PI3K signal transduction pathway and siRNA-based therapy
12/08/2005US20050272681 Ribosome structure and protein synthesis inhibitors
12/08/2005US20050272680 Oligonucleotide sequences for use in controlling diacylglycerol acyltransferase 2 a nd treatment and prevention of diabetes, liver and cardiovascular disorders; antisense agents
12/08/2005US20050272654 NF-kappaB activation inhibitors, and their pharmaceutical uses
12/08/2005US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use
12/08/2005US20050272156 Utilizes one or more sets of electrodes spaced to hold surface tension of sample receiving pulses; for gene discovery/therapy/tissue engineering
12/08/2005US20050272155 Methods and compositions for enhancing cell adhesion properties
12/08/2005US20050272154 Alkylation of a nucleic acid at the N7 position of a guanine nucleotide; improved genetic transduction; maintained genetic expressibility; gene therapy
12/08/2005US20050272148 Method of collecting placental stem cells
12/08/2005US20050272140 Methods for generating hypermutable yeast
12/08/2005US20050272136 Process for producing 3-hydroxycyclohexanone
12/08/2005US20050272133 A C9-deoxomeridamycin, used as a neuroregenerative agent
12/08/2005US20050272132 For therapy of a fungal infection
12/08/2005US20050272130 Methods and compositions relating to prion-only transmission of yeast strains
12/08/2005US20050272129 Filamentous fungus belonging to a species Colletotrichum gloeosporioides or Aspergillus niger; improved biomass production in solid and liquid culture; for biocontrol
12/08/2005US20050272128 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
12/08/2005US20050272127 Antibody against an angiogenesis-inhibiting peptide homologous to human ChM1L chondromodulin-I (ChM-I); hybridomas; diagnostic kits; controlling angiogenesis
12/08/2005US20050272126 Testis-specific differentiation-regulatory factor
12/08/2005US20050272121 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination
12/08/2005US20050272118 biological conjugated drug binding with a detectable label, or toxin maytansine and calicheamicin; monoclonal antibody as antiinflammatory agents in the therapeutic treatment and diagnostic detection of immune disorders in mammals; biodrugs
12/08/2005US20050272107 Intracellular antibodies
12/08/2005US20050272099 Nucleic acids encoding androgen receptorl drug screening
12/08/2005US20050272092 Novel gene having reverse transcriptas motif
12/08/2005US20050272091 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection
12/08/2005US20050272090 Nucleic acid binding of multi-zinc finger transcription factors
12/08/2005US20050272086 Methods for genomic analysis
12/08/2005US20050272081 Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule
1 ... 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 ... 4023